Search research articles
Contact Us
Filters
Showing results (711-720 of 1,145) with videos related to
Page
of 115
Sort By:
Cancer Research
|
May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer
John W M Martens, Inko Nimmrich, Thomas Koenig, et al.
Clinical Genitourinary Cancer
|
December 11, 2024
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy
Carolin Siech, Simone Morra, Lukas Scheipner, et al.
Molecular Oncology
|
November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer
Doris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis
|
October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy
Maria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
The Prostate
|
November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers
Sarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget
|
August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
Cornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Breast Cancer Research and Treatment
|
October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients
Inko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Oncotarget
|
January 10, 2018
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer
Martina Kluth, Simon Jung, Omar Habib, et al.
Diagnostics (Basel, Switzerland)
|
October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells
Maximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology
|
April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
Katharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Page
of 115
Search research articles
Search
Showing results (711-720 of 1,145) with videos related to
Sort By:
Page
of 115
Cancer Research
|
May 19, 2005
Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer
John W M Martens, Inko Nimmrich, Thomas Koenig, et al.
Clinical Genitourinary Cancer
|
December 11, 2024
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy
Carolin Siech, Simone Morra, Lukas Scheipner, et al.
Molecular Oncology
|
November 19, 2019
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer
Doris Höflmayer, Amélie Steinhoff, Claudia Hube-Magg, et al.
Carcinogenesis
|
October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy
Maria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
The Prostate
|
November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers
Sarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget
|
August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy
Cornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Breast Cancer Research and Treatment
|
October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients
Inko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.
Oncotarget
|
January 10, 2018
Deletion lengthening at chromosomes 6q and 16q targets multiple tumor suppressor genes and is associated with an increasingly poor prognosis in prostate cancer
Martina Kluth, Simon Jung, Omar Habib, et al.
Diagnostics (Basel, Switzerland)
|
October 27, 2022
Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells
Maximilian Lennartz, Dennis Atug, Sebastian Dwertmann Rico, et al.
International Urology and Nephrology
|
April 2, 2021
Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
Katharina Möller, Christoph Fraune, Niclas C Blessin, et al.
Page
of 115